195 related articles for article (PubMed ID: 31448844)
1. Tubular aggregate myopathy and Stormorken syndrome: Mutation spectrum and genotype/phenotype correlation.
Morin G; Biancalana V; Echaniz-Laguna A; Noury JB; Lornage X; Moggio M; Ripolone M; Violano R; Marcorelles P; Maréchal D; Renaud F; Maurage CA; Tard C; Cuisset JM; Laporte J; Böhm J
Hum Mutat; 2020 Jan; 41(1):17-37. PubMed ID: 31448844
[TBL] [Abstract][Full Text] [Related]
2. [Tubular aggregate myopathy and Stormorken syndrome].
Böhm J; Laporte J
Med Sci (Paris); 2018 Nov; 34 Hors série n°2():26-31. PubMed ID: 30418142
[TBL] [Abstract][Full Text] [Related]
3. Gain-of-function mutations in STIM1 and ORAI1 causing tubular aggregate myopathy and Stormorken syndrome.
Böhm J; Laporte J
Cell Calcium; 2018 Dec; 76():1-9. PubMed ID: 30243034
[TBL] [Abstract][Full Text] [Related]
4. Functional analyses of STIM1 mutations reveal a common pathomechanism for tubular aggregate myopathy and Stormorken syndrome.
Peche GA; Spiegelhalter C; Silva-Rojas R; Laporte J; Böhm J
Neuropathology; 2020 Dec; 40(6):559-569. PubMed ID: 33073872
[TBL] [Abstract][Full Text] [Related]
5. ORAI1 Mutations with Distinct Channel Gating Defects in Tubular Aggregate Myopathy.
Böhm J; Bulla M; Urquhart JE; Malfatti E; Williams SG; O'Sullivan J; Szlauer A; Koch C; Baranello G; Mora M; Ripolone M; Violano R; Moggio M; Kingston H; Dawson T; DeGoede CG; Nixon J; Boland A; Deleuze JF; Romero N; Newman WG; Demaurex N; Laporte J
Hum Mutat; 2017 Apr; 38(4):426-438. PubMed ID: 28058752
[TBL] [Abstract][Full Text] [Related]
6. STIM1 over-activation generates a multi-systemic phenotype affecting the skeletal muscle, spleen, eye, skin, bones and immune system in mice.
Silva-Rojas R; Treves S; Jacobs H; Kessler P; Messaddeq N; Laporte J; Böhm J
Hum Mol Genet; 2019 May; 28(10):1579-1593. PubMed ID: 30576443
[TBL] [Abstract][Full Text] [Related]
7. Silencing of the Ca
Silva-Rojas R; Pérez-Guàrdia L; Lafabrie E; Moulaert D; Laporte J; Böhm J
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805973
[TBL] [Abstract][Full Text] [Related]
8. Activating mutations in STIM1 and ORAI1 cause overlapping syndromes of tubular myopathy and congenital miosis.
Nesin V; Wiley G; Kousi M; Ong EC; Lehmann T; Nicholl DJ; Suri M; Shahrizaila N; Katsanis N; Gaffney PM; Wierenga KJ; Tsiokas L
Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4197-202. PubMed ID: 24591628
[TBL] [Abstract][Full Text] [Related]
9. CRAC channels and disease - From human CRAC channelopathies and animal models to novel drugs.
Feske S
Cell Calcium; 2019 Jun; 80():112-116. PubMed ID: 31009822
[TBL] [Abstract][Full Text] [Related]
10. ORAI1 inhibition as an efficient preclinical therapy for tubular aggregate myopathy and Stormorken syndrome.
Silva-Rojas R; Pérez-Guàrdia L; Simon A; Djeddi S; Treves S; Ribes A; Silva-Hernández L; Tard C; Laporte J; Böhm J
JCI Insight; 2024 Mar; 9(6):. PubMed ID: 38516893
[TBL] [Abstract][Full Text] [Related]
11. Tubular aggregate myopathy with features of Stormorken disease due to a new STIM1 mutation.
Noury JB; Böhm J; Peche GA; Guyant-Marechal L; Bedat-Millet AL; Chiche L; Carlier RY; Malfatti E; Romero NB; Stojkovic T
Neuromuscul Disord; 2017 Jan; 27(1):78-82. PubMed ID: 27876257
[TBL] [Abstract][Full Text] [Related]
12. Complex phenotypes associated with STIM1 mutations in both coiled coil and EF-hand domains.
Harris E; Burki U; Marini-Bettolo C; Neri M; Scotton C; Hudson J; Bertoli M; Evangelista T; Vroling B; Polvikoski T; Roberts M; Töpf A; Bushby K; McArthur D; Lochmüller H; Ferlini A; Straub V; Barresi R
Neuromuscul Disord; 2017 Sep; 27(9):861-872. PubMed ID: 28624464
[TBL] [Abstract][Full Text] [Related]
13. A dominant STIM1 mutation causes Stormorken syndrome.
Misceo D; Holmgren A; Louch WE; Holme PA; Mizobuchi M; Morales RJ; De Paula AM; Stray-Pedersen A; Lyle R; Dalhus B; Christensen G; Stormorken H; Tjønnfjord GE; Frengen E
Hum Mutat; 2014 May; 35(5):556-64. PubMed ID: 24619930
[TBL] [Abstract][Full Text] [Related]
14. STIM1 and ORAI1 mutations leading to tubular aggregate myopathies are sensitive to the Store-operated Ca
Riva B; Pessolano E; Quaglia E; Cordero-Sanchez C; Bhela IP; Topf A; Serafini M; Cox D; Harris E; Garibaldi M; Barresi R; Pirali T; Genazzani AA
Cell Calcium; 2022 Jul; 105():102605. PubMed ID: 35636153
[TBL] [Abstract][Full Text] [Related]
15. A dual mechanism promotes switching of the Stormorken STIM1 R304W mutant into the activated state.
Fahrner M; Stadlbauer M; Muik M; Rathner P; Stathopulos P; Ikura M; Müller N; Romanin C
Nat Commun; 2018 Feb; 9(1):825. PubMed ID: 29483506
[TBL] [Abstract][Full Text] [Related]
16. Case Report: Novel STIM1 Gain-of-Function Mutation in a Patient With TAM/STRMK and Immunological Involvement.
de la Fuente-Munoz E; Van Den Rym A; García-Solis B; Ochoa Grullón J; Guevara-Hoyer K; Fernández-Arquero M; Galán Dávila L; Matías-Guiú J; Sánchez-Ramón S; Pérez de Diego R
Front Immunol; 2022; 13():917601. PubMed ID: 35812399
[TBL] [Abstract][Full Text] [Related]
17. Gain-of-Function Mutation in STIM1 (P.R304W) Is Associated with Stormorken Syndrome.
Morin G; Bruechle NO; Singh AR; Knopp C; Jedraszak G; Elbracht M; Brémond-Gignac D; Hartmann K; Sevestre H; Deutz P; Hérent D; Nürnberg P; Roméo B; Konrad K; Mathieu-Dramard M; Oldenburg J; Bourges-Petit E; Shen Y; Zerres K; Ouadid-Ahidouch H; Rochette J
Hum Mutat; 2014 Oct; 35(10):1221-32. PubMed ID: 25044882
[TBL] [Abstract][Full Text] [Related]
18. York platelet syndrome is a CRAC channelopathy due to gain-of-function mutations in STIM1.
Markello T; Chen D; Kwan JY; Horkayne-Szakaly I; Morrison A; Simakova O; Maric I; Lozier J; Cullinane AR; Kilo T; Meister L; Pakzad K; Bone W; Chainani S; Lee E; Links A; Boerkoel C; Fischer R; Toro C; White JG; Gahl WA; Gunay-Aygun M
Mol Genet Metab; 2015 Mar; 114(3):474-82. PubMed ID: 25577287
[TBL] [Abstract][Full Text] [Related]
19.
Silva-Rojas R; Laporte J; Böhm J
Front Physiol; 2020; 11():604941. PubMed ID: 33250786
[TBL] [Abstract][Full Text] [Related]
20. Stormorken Syndrome: A Rare Cause of Myopathy With Tubular Aggregates and Dystrophic Features.
Li A; Kang X; Edelman F; Waclawik AJ
J Child Neurol; 2019 May; 34(6):321-324. PubMed ID: 30761937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]